Clinical Trial Update: Efficacy of Tocilizumab in Primary Sjögren's Syndrome. [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluated the efficacy of tocilizumab in patients with Primary Sjögren's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Primary Sjögren's Syndrome (pSS) | Phase 2, Phase 3 | Status: COMPLETED